|
EIARD+ |
EIARD- |
p |
EIARD+ |
EIARD- |
p |
Age at EPT (years) |
10.2 |
10.6 |
0.52 |
9.4 |
9.3 |
0.94 |
|
(6.5–15.7) |
(6.2–14.4) |
|
(5.5–16) |
(6.3–13.4) |
|
History of atopic dermatitis, n (%) |
15 (71%) |
16 (73%) |
1 |
9
(60%) |
14 (88%) |
0.11 |
History of bronchial asthma, n (%) |
12 (57%) |
10 (45%) |
0.55 |
7
(47%) |
6 (38%) |
0.72 |
History of allergic rhinitis, n (%) |
17 (81%) |
17 (77%) |
1 |
12
(80%) |
9 (56%) |
0.25 |
Age at starting slow OIT (years) |
5.1 |
5.9 |
0.95 |
6 |
5.2 |
0.4 |
|
(2.2–11.5) |
(1.6–10.8) |
|
(1.7–13.8) |
(1.1–10.6) |
|
OIT initial dose
(mg of cow’s milk or wheat protein)
|
165
|
49.5
|
0.713
|
26
|
26
|
0.51
|
|
(3–1650) |
(7–330) |
|
(2–260) |
(5–260) |
|
OIT initial dose, n |
|
|
|
|
|
|
≥66 mg cow’s milk protein or ≥52 mg wheat protein |
16 |
10 |
0.11 |
6 |
5 |
1 |
<66 mg cow’s milk protein or <52 mg wheat protein |
5 |
10 |
|
8 |
8 |
|
Duration from starting OIT to |
2.7 |
2.6 |
0.49 |
2 |
2.9 |
0.053 |
the full dose (years) |
(0.6–6.9) |
(0.3–5.1) |
|
(0.7–7) |
(1.1–6) |
|
Average pace of |
2422 |
2570 |
0.52 |
3349 |
2314 |
0.053 |
increasing intake (mg/years) |
|
|
|
|
|
|
Duration from starting OIT to |
4.2 |
4.4 |
0.83 |
3.4 |
4.2 |
0.41 |
the EPT (years) |
(0.7–10.4) |
(0.7–8.8) |
|
(1.9–7.7) |
(1.7–9.7) |
|
sIgE (crude) before OIT (kUA/L) |
15.7 |
20.2 |
0.51 |
21.9 |
17.3 |
0.93 |
|
(3.22–100) |
(1.33–100) |
|
(1.36–100) |
(4.22–100) |
|
sIgE (component) before OIT (kUA/L) |
14 |
22.4 |
0.96 |
3.22 |
0.54 |
0.23 |
|
(4–100) |
(5.47–100) |
|
(0.34–16.7) |
(0.34–5.95) |
|